Tag: Biocad

BIOCAD will localize its manufacturing in Finland

BIOCAD, a biotech company, is expanding its presence in international markets.

BIOCAD wins tender for the supply of Trastuzumab to Syria

This is the first tender which BIOCAD has won in Syria.

Russian biosimilars for rheumatic diseases will reduce the therapy costs

New products developed by BIOCAD, a Russian biotech company, can cut down by 30 to 50% the costs of annual treatment course with genetically engineered drugs for patients with rheumatic diseases. The ...

BIOCAD will continue to supply biosimilar of rituximab to Vietnam

In March, BIOCAD, a biotech company, has for the second time received a quota to supply a biosimilar of rituximab to Vietnam. This means that BIOCAD partners will continue to supply local hospitals wi...

BIOCAD launches a drug labeling information system

In mid-March, BIOCAD, a biotech company, launched in operating mode a Track&Trace system for its three products. This is a pilot project implemented as part of the experiment to label certain medi...

Pharmasyntez and Biocad are in top 10 Russian hospital procurement manufacturers

According to the hospital audit of Russian pharmaceutical market conducted by DSM Group, in 2016, 882.2 million packages of medicinal products worth 221.9 billion rubles were purchased for hospitals i...

Equipment for labelling drugs will not cost more than 150,000 euros

The cost of equipment required for labelling drugs on one production line of a pharmaceutical plant does not exceed €150,000. This was reported in an interview with TASS by Dmitry Morozov, General Dir...

BIOCAD’s first biosimilar of interferon beta-1a approved in Russia

The Ministry of Health (MoH) of the Russian Federation has awarded Biocad marketing authorization for its interferon beta-1a biosimilar, a knockoff of Biogen's Rebif® that is a key component in treatm...

BIOCAD will invest 20 bln rubles in production development

In the near 3-5 years BIOCAD Company is going to invest 20 bln rubles in development of its production facilities in St.Petersburg. Biotechnological company BIOCAD has started several projects at once...

Biocad will launch new anti-cancer drug in Russia

Russia’s leading biotech firm Biocad is finishing clinical trials of a new anti-cancer drug that will soon appear in the Russian market and will be able to compete with imported analogues, according t...

Vladimir Putin and Nursultan Nazarbayev visited the scientific-research center BIOCAD

"Biocad" Director General Dmitry Morozov gives an explanation
Presidents of Russia Vladimir Putin and President of Kazakhstan Nursultan Nazarbaev visited the plant and scientific-research center BIOCAD Russian biotech company in the special economic zone "Neudor...